Considering the non-selective binding properties of [18F]THK-5351 to MAO-B and AD-tau, [18F]THK-5351 is likely to be useful in non-AD patients whose brains are not expected to harbor tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.